HEADER TRANSPORT PROTEIN 23-SEP-03 1R10 TITLE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) NUCLEOTIDE- TITLE 2 BINDING DOMAIN ONE (NBD1) WITH ATP, I4122 SPACE GROUP COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: NBD1 DOMAIN (RESIDUES 389-673); COMPND 5 SYNONYM: CFTR, CAMP- DEPENDENT CHLORIDE CHANNEL; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: CFTR OR ABCC7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET26B KEYWDS ABC TRANSPORTER NUCLEOTIDE BINDING DOMAIN, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.A.LEWIS,S.G.BUCHANAN,S.K.BURLEY,K.CONNERS,M.DICKEY,M.DORWART, AUTHOR 2 R.FOWLER,X.GAO,W.B.GUGGINO,W.A.HENDRICKSON REVDAT 6 14-FEB-24 1R10 1 REMARK REVDAT 5 03-FEB-21 1R10 1 AUTHOR JRNL REMARK SEQADV REVDAT 5 2 1 LINK REVDAT 4 13-JUL-11 1R10 1 VERSN REVDAT 3 24-FEB-09 1R10 1 VERSN REVDAT 2 14-DEC-04 1R10 1 JRNL REMARK REVDAT 1 09-DEC-03 1R10 0 JRNL AUTH H.A.LEWIS,S.G.BUCHANAN,S.K.BURLEY,K.CONNERS,M.DICKEY, JRNL AUTH 2 M.DORWART,R.FOWLER,X.GAO,W.B.GUGGINO,W.A.HENDRICKSON, JRNL AUTH 3 J.F.HUNT,M.C.KEARINS,D.LORIMER,P.C.MALONEY,K.W.POST, JRNL AUTH 4 K.R.RAJASHANKAR,M.E.RUTTER,J.M.SAUDER,S.SHRIVER, JRNL AUTH 5 P.H.THIBODEAU,P.J.THOMAS,M.ZHANG,X.ZHAO,S.EMTAGE JRNL TITL STRUCTURE OF NUCLEOTIDE-BINDING DOMAIN 1 OF THE CYSTIC JRNL TITL 2 FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR. JRNL REF EMBO J. V. 23 282 2004 JRNL REFN ISSN 0261-4189 JRNL PMID 14685259 JRNL DOI 10.1038/SJ.EMBOJ.7600040 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 28507 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1443 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4164 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1R10 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1000020308. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JAN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SILICON 220 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28573 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 49.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.98000 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 77.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM ACETATE, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 -X+1/2,Y,-Z+3/4 REMARK 290 6555 X,-Y+1/2,-Z+1/4 REMARK 290 7555 Y+1/2,X+1/2,-Z+1/2 REMARK 290 8555 -Y,-X,-Z REMARK 290 9555 X+1/2,Y+1/2,Z+1/2 REMARK 290 10555 -X,-Y,Z REMARK 290 11555 -Y+1/2,X,Z+3/4 REMARK 290 12555 Y,-X+1/2,Z+1/4 REMARK 290 13555 -X,Y+1/2,-Z+1/4 REMARK 290 14555 X+1/2,-Y,-Z+3/4 REMARK 290 15555 Y,X,-Z REMARK 290 16555 -Y+1/2,-X+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 70.60000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 70.60000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 139.73000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 70.60000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 69.86500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 70.60000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 209.59500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 70.60000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 209.59500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 70.60000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 69.86500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 70.60000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 70.60000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 139.73000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 70.60000 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 70.60000 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 139.73000 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 11 0.000000 -1.000000 0.000000 70.60000 REMARK 290 SMTRY2 11 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 1.000000 209.59500 REMARK 290 SMTRY1 12 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 12 -1.000000 0.000000 0.000000 70.60000 REMARK 290 SMTRY3 12 0.000000 0.000000 1.000000 69.86500 REMARK 290 SMTRY1 13 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 70.60000 REMARK 290 SMTRY3 13 0.000000 0.000000 -1.000000 69.86500 REMARK 290 SMTRY1 14 1.000000 0.000000 0.000000 70.60000 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 14 0.000000 0.000000 -1.000000 209.59500 REMARK 290 SMTRY1 15 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 15 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 16 0.000000 -1.000000 0.000000 70.60000 REMARK 290 SMTRY2 16 -1.000000 0.000000 0.000000 70.60000 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 139.73000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 25370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 80950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -205.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 141.20000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 141.20000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 558.92000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 282.40000 REMARK 350 BIOMT2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 141.20000 REMARK 350 BIOMT2 4 1.000000 0.000000 0.000000 -141.20000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 558.92000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 388 REMARK 465 THR A 389 REMARK 465 THR A 390 REMARK 465 GLN A 413 REMARK 465 GLN A 414 REMARK 465 SER A 415 REMARK 465 ASN A 416 REMARK 465 GLY A 417 REMARK 465 ASP A 418 REMARK 465 ARG A 419 REMARK 465 LYS A 420 REMARK 465 HIS A 421 REMARK 465 SER A 422 REMARK 465 SER A 423 REMARK 465 ASP A 424 REMARK 465 GLU A 425 REMARK 465 ASN A 426 REMARK 465 ASN A 427 REMARK 465 VAL A 428 REMARK 465 VAL A 671 REMARK 465 ASP A 672 REMARK 465 ASP A 673 REMARK 465 SER B 388 REMARK 465 THR B 389 REMARK 465 THR B 390 REMARK 465 GLN B 413 REMARK 465 GLN B 414 REMARK 465 SER B 415 REMARK 465 ASN B 416 REMARK 465 GLY B 417 REMARK 465 ASP B 418 REMARK 465 ARG B 419 REMARK 465 LYS B 420 REMARK 465 HIS B 421 REMARK 465 SER B 422 REMARK 465 SER B 423 REMARK 465 ASP B 424 REMARK 465 GLU B 425 REMARK 465 ASN B 426 REMARK 465 ASN B 427 REMARK 465 VAL B 428 REMARK 465 VAL B 671 REMARK 465 ASP B 672 REMARK 465 ASP B 673 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 396 80.55 12.62 REMARK 500 LYS A 450 127.98 -39.67 REMARK 500 GLN A 536 -140.60 51.84 REMARK 500 LYS A 564 132.91 -38.45 REMARK 500 PHE A 575 72.61 -103.24 REMARK 500 CYS A 590 -69.78 -91.51 REMARK 500 LYS A 593 -92.97 -78.68 REMARK 500 ARG A 611 -72.09 -35.44 REMARK 500 LYS A 612 7.29 -69.86 REMARK 500 PHE A 626 149.87 -170.96 REMARK 500 PHE A 640 -77.45 -42.37 REMARK 500 ASP A 648 -81.00 -53.68 REMARK 500 PHE A 669 60.67 -115.68 REMARK 500 ASN B 396 79.27 29.53 REMARK 500 LYS B 450 128.78 -21.82 REMARK 500 PHE B 508 96.75 -50.75 REMARK 500 ASP B 529 -63.60 -98.09 REMARK 500 GLN B 536 -134.06 49.96 REMARK 500 GLU B 543 127.16 -1.26 REMARK 500 PHE B 575 58.26 -103.23 REMARK 500 LYS B 593 -82.73 -85.48 REMARK 500 ARG B 611 -77.20 -46.08 REMARK 500 LYS B 612 0.33 -57.08 REMARK 500 ASP B 648 -70.38 -74.39 REMARK 500 ASP B 651 1.48 -62.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP B 579 VAL B 580 -146.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 3 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ATP A 1 O2G REMARK 620 2 ATP A 1 O2B 67.1 REMARK 620 3 THR A 465 OG1 109.0 69.8 REMARK 620 4 GLN A 493 OE1 84.1 130.1 83.7 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 4 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ATP B 2 O2G REMARK 620 2 ATP B 2 O2B 64.3 REMARK 620 3 THR B 465 OG1 112.2 62.4 REMARK 620 4 GLN B 493 OE1 89.0 134.8 100.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY B 8 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 9 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1R0W RELATED DB: PDB REMARK 900 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) REMARK 900 NUCLEOTIDE-BINDING DOMAIN ONE (NBD1) APO REMARK 900 RELATED ID: 1R0X RELATED DB: PDB REMARK 900 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) REMARK 900 NUCLEOTIDE-BINDING DOMAIN ONE (NBD1) WITH ATP REMARK 900 RELATED ID: 1R0Y RELATED DB: PDB REMARK 900 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) REMARK 900 NUCLEOTIDE-BINDING DOMAIN ONE (NBD1) WITH ADP REMARK 900 RELATED ID: 1R0Z RELATED DB: PDB REMARK 900 PHOSPHORYLATED CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR REMARK 900 (CFTR) NUCLEOTIDE-BINDING DOMAIN ONE (NBD1) WITH ATP DBREF 1R10 A 389 673 UNP P26361 CFTR_MOUSE 389 673 DBREF 1R10 B 389 673 UNP P26361 CFTR_MOUSE 389 673 SEQADV 1R10 SER A 388 UNP P26361 CLONING ARTIFACT SEQADV 1R10 SER B 388 UNP P26361 CLONING ARTIFACT SEQRES 1 A 286 SER THR THR GLY ILE ILE MET GLU ASN VAL THR ALA PHE SEQRES 2 A 286 TRP GLU GLU GLY PHE GLY GLU LEU LEU GLU LYS VAL GLN SEQRES 3 A 286 GLN SER ASN GLY ASP ARG LYS HIS SER SER ASP GLU ASN SEQRES 4 A 286 ASN VAL SER PHE SER HIS LEU CYS LEU VAL GLY ASN PRO SEQRES 5 A 286 VAL LEU LYS ASN ILE ASN LEU ASN ILE GLU LYS GLY GLU SEQRES 6 A 286 MET LEU ALA ILE THR GLY SER THR GLY SER GLY LYS THR SEQRES 7 A 286 SER LEU LEU MET LEU ILE LEU GLY GLU LEU GLU ALA SER SEQRES 8 A 286 GLU GLY ILE ILE LYS HIS SER GLY ARG VAL SER PHE CYS SEQRES 9 A 286 SER GLN PHE SER TRP ILE MET PRO GLY THR ILE LYS GLU SEQRES 10 A 286 ASN ILE ILE PHE GLY VAL SER TYR ASP GLU TYR ARG TYR SEQRES 11 A 286 LYS SER VAL VAL LYS ALA CYS GLN LEU GLN GLN ASP ILE SEQRES 12 A 286 THR LYS PHE ALA GLU GLN ASP ASN THR VAL LEU GLY GLU SEQRES 13 A 286 GLY GLY VAL THR LEU SER GLY GLY GLN ARG ALA ARG ILE SEQRES 14 A 286 SER LEU ALA ARG ALA VAL TYR LYS ASP ALA ASP LEU TYR SEQRES 15 A 286 LEU LEU ASP SER PRO PHE GLY TYR LEU ASP VAL PHE THR SEQRES 16 A 286 GLU GLU GLN VAL PHE GLU SER CYS VAL CYS LYS LEU MET SEQRES 17 A 286 ALA ASN LYS THR ARG ILE LEU VAL THR SER LYS MET GLU SEQRES 18 A 286 HIS LEU ARG LYS ALA ASP LYS ILE LEU ILE LEU HIS GLN SEQRES 19 A 286 GLY SER SER TYR PHE TYR GLY THR PHE SER GLU LEU GLN SEQRES 20 A 286 SER LEU ARG PRO ASP PHE SER SER LYS LEU MET GLY TYR SEQRES 21 A 286 ASP THR PHE ASP GLN PHE THR GLU GLU ARG ARG SER SER SEQRES 22 A 286 ILE LEU THR GLU THR LEU ARG ARG PHE SER VAL ASP ASP SEQRES 1 B 286 SER THR THR GLY ILE ILE MET GLU ASN VAL THR ALA PHE SEQRES 2 B 286 TRP GLU GLU GLY PHE GLY GLU LEU LEU GLU LYS VAL GLN SEQRES 3 B 286 GLN SER ASN GLY ASP ARG LYS HIS SER SER ASP GLU ASN SEQRES 4 B 286 ASN VAL SER PHE SER HIS LEU CYS LEU VAL GLY ASN PRO SEQRES 5 B 286 VAL LEU LYS ASN ILE ASN LEU ASN ILE GLU LYS GLY GLU SEQRES 6 B 286 MET LEU ALA ILE THR GLY SER THR GLY SER GLY LYS THR SEQRES 7 B 286 SER LEU LEU MET LEU ILE LEU GLY GLU LEU GLU ALA SER SEQRES 8 B 286 GLU GLY ILE ILE LYS HIS SER GLY ARG VAL SER PHE CYS SEQRES 9 B 286 SER GLN PHE SER TRP ILE MET PRO GLY THR ILE LYS GLU SEQRES 10 B 286 ASN ILE ILE PHE GLY VAL SER TYR ASP GLU TYR ARG TYR SEQRES 11 B 286 LYS SER VAL VAL LYS ALA CYS GLN LEU GLN GLN ASP ILE SEQRES 12 B 286 THR LYS PHE ALA GLU GLN ASP ASN THR VAL LEU GLY GLU SEQRES 13 B 286 GLY GLY VAL THR LEU SER GLY GLY GLN ARG ALA ARG ILE SEQRES 14 B 286 SER LEU ALA ARG ALA VAL TYR LYS ASP ALA ASP LEU TYR SEQRES 15 B 286 LEU LEU ASP SER PRO PHE GLY TYR LEU ASP VAL PHE THR SEQRES 16 B 286 GLU GLU GLN VAL PHE GLU SER CYS VAL CYS LYS LEU MET SEQRES 17 B 286 ALA ASN LYS THR ARG ILE LEU VAL THR SER LYS MET GLU SEQRES 18 B 286 HIS LEU ARG LYS ALA ASP LYS ILE LEU ILE LEU HIS GLN SEQRES 19 B 286 GLY SER SER TYR PHE TYR GLY THR PHE SER GLU LEU GLN SEQRES 20 B 286 SER LEU ARG PRO ASP PHE SER SER LYS LEU MET GLY TYR SEQRES 21 B 286 ASP THR PHE ASP GLN PHE THR GLU GLU ARG ARG SER SER SEQRES 22 B 286 ILE LEU THR GLU THR LEU ARG ARG PHE SER VAL ASP ASP HET MG A 3 1 HET ATP A 1 31 HET ACY A 7 4 HET ACY A 9 4 HET MG B 4 1 HET ATP B 2 31 HET ACY B 8 4 HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM ACY ACETIC ACID FORMUL 3 MG 2(MG 2+) FORMUL 4 ATP 2(C10 H16 N5 O13 P3) FORMUL 5 ACY 3(C2 H4 O2) HELIX 1 1 GLY A 404 VAL A 412 1 9 HELIX 2 2 SER A 429 GLY A 437 1 9 HELIX 3 3 GLY A 463 LEU A 472 1 10 HELIX 4 4 ILE A 502 ILE A 507 1 6 HELIX 5 5 ASP A 513 CYS A 524 1 12 HELIX 6 6 LEU A 526 THR A 531 1 6 HELIX 7 7 GLU A 535 ASN A 538 5 4 HELIX 8 8 SER A 549 LYS A 564 1 16 HELIX 9 9 ASP A 579 CYS A 590 1 12 HELIX 10 10 LYS A 606 LYS A 612 1 7 HELIX 11 11 THR A 629 ARG A 637 1 9 HELIX 12 12 ARG A 637 GLY A 646 1 10 HELIX 13 13 THR A 649 PHE A 653 5 5 HELIX 14 14 THR A 654 PHE A 669 1 16 HELIX 15 15 GLY B 404 LYS B 411 1 8 HELIX 16 16 SER B 429 GLY B 437 1 9 HELIX 17 17 GLY B 463 LEU B 472 1 10 HELIX 18 18 ILE B 502 ILE B 507 1 6 HELIX 19 19 ASP B 513 CYS B 524 1 12 HELIX 20 20 LEU B 526 THR B 531 1 6 HELIX 21 21 GLU B 535 ASN B 538 5 4 HELIX 22 22 SER B 549 TYR B 563 1 15 HELIX 23 23 ASP B 579 VAL B 591 1 13 HELIX 24 24 LYS B 606 LYS B 612 1 7 HELIX 25 25 THR B 629 ARG B 637 1 9 HELIX 26 26 ARG B 637 GLY B 646 1 10 HELIX 27 27 THR B 649 PHE B 653 5 5 HELIX 28 28 THR B 654 PHE B 669 1 16 SHEET 1 A 3 PRO A 439 ILE A 448 0 SHEET 2 A 3 ILE A 392 PHE A 400 -1 N MET A 394 O LEU A 446 SHEET 3 A 3 ALA A 477 HIS A 484 -1 O LYS A 483 N ILE A 393 SHEET 1 B 6 VAL A 488 CYS A 491 0 SHEET 2 B 6 LEU A 568 ASP A 572 1 O LEU A 570 N SER A 489 SHEET 3 B 6 THR A 599 VAL A 603 1 O VAL A 603 N LEU A 571 SHEET 4 B 6 MET A 453 GLY A 458 1 N LEU A 454 O LEU A 602 SHEET 5 B 6 LYS A 615 HIS A 620 1 O LEU A 617 N THR A 457 SHEET 6 B 6 SER A 623 GLY A 628 -1 O SER A 623 N HIS A 620 SHEET 1 C 2 GLY A 500 THR A 501 0 SHEET 2 C 2 VAL A 540 LEU A 541 -1 O LEU A 541 N GLY A 500 SHEET 1 D 3 PRO B 439 ILE B 448 0 SHEET 2 D 3 ILE B 392 PHE B 400 -1 N MET B 394 O LEU B 446 SHEET 3 D 3 ALA B 477 LYS B 483 -1 O LYS B 483 N ILE B 393 SHEET 1 E 6 VAL B 488 CYS B 491 0 SHEET 2 E 6 LEU B 568 ASP B 572 1 O LEU B 570 N SER B 489 SHEET 3 E 6 THR B 599 VAL B 603 1 O ILE B 601 N LEU B 571 SHEET 4 E 6 MET B 453 GLY B 458 1 N LEU B 454 O LEU B 602 SHEET 5 E 6 LYS B 615 HIS B 620 1 O LEU B 619 N THR B 457 SHEET 6 E 6 SER B 623 GLY B 628 -1 O TYR B 625 N ILE B 618 SHEET 1 F 2 GLY B 500 THR B 501 0 SHEET 2 F 2 VAL B 540 LEU B 541 -1 O LEU B 541 N GLY B 500 LINK O2G ATP A 1 MG MG A 3 1555 1555 2.63 LINK O2B ATP A 1 MG MG A 3 1555 1555 2.61 LINK MG MG A 3 OG1 THR A 465 1555 1555 2.41 LINK MG MG A 3 OE1 GLN A 493 1555 1555 3.10 LINK O2G ATP B 2 MG MG B 4 1555 1555 2.51 LINK O2B ATP B 2 MG MG B 4 1555 1555 2.92 LINK MG MG B 4 OG1 THR B 465 1555 1555 2.50 LINK MG MG B 4 OE1 GLN B 493 1555 1555 2.66 SITE 1 AC1 4 ATP A 1 THR A 465 GLN A 493 ASP A 572 SITE 1 AC2 4 ATP B 2 THR B 465 GLN B 493 ASP B 572 SITE 1 AC3 11 MG A 3 TRP A 401 LEU A 409 PHE A 430 SITE 2 AC3 11 GLY A 461 SER A 462 GLY A 463 LYS A 464 SITE 3 AC3 11 THR A 465 SER A 466 MET B 498 SITE 1 AC4 11 MG B 4 TRP B 401 GLU B 410 THR B 460 SITE 2 AC4 11 GLY B 461 SER B 462 GLY B 463 LYS B 464 SITE 3 AC4 11 THR B 465 SER B 466 GLN B 493 SITE 1 AC5 4 GLY A 542 GLY A 545 VAL A 546 THR A 547 SITE 1 AC6 6 LEU A 578 LEU B 541 GLY B 542 GLY B 545 SITE 2 AC6 6 VAL B 546 THR B 547 SITE 1 AC7 4 ASP A 529 LYS A 532 LYS B 532 GLN B 552 CRYST1 141.200 141.200 279.460 90.00 90.00 90.00 I 41 2 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007082 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007082 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003578 0.00000